Answers are grounded in this paper and cite their sources.
Chronic rhinosinusitis (CRS) is a common disease with increasing global prevalence that significantly impacts patients' quality of life. Advances in surgical technology and a better understanding of mucosal pathophysiology have transformed its management landscape. However, a notable gap remains in the published literature. This article reviews the evolution of endonasal sinus surgery and presents a position on the emerging concept of "Thinvasive" surgery, a minimally invasive and function-preserving paradigm for the modern management of CRS. A comprehensive review of the historical development, current techniques, and novel approaches in endoscopic sinus surgery was conducted. The transition from traditional external procedures, such as Caldwell-Luc, to functional endoscopic sinus surgery (FESS) marked a pivotal shift toward mucosal preservation and restoration of physiological drainage. Further advancements, such as image-guided FESS, balloon sinuplasty, and other minimal-access modalities, have facilitated more precise and individualized interventions. The Thinvasive approach integrates these innovations with patient-specific assessment strategies, including radiologic and functional evaluation tools like the Sino-Nasal Outcome Test-22, quantum molecular resonance (Telea Medical, Sandrigo, Italy), and Ozilia-kinetic oscillation stimulation (Chordate Medical, Kista, Sweden). The future of endonasal sinus surgery lies in a flexible and personalized continuum. Thinvasive techniques offer a promising hybrid between medical and surgical treatment. Nonetheless, further research is needed to establish their long-term efficacy and to develop standardized patient selection frameworks.
No takes yet. Share an insight, caveat, or question.
Businco et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: